Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1054_Библиотеки_им_академика_М_И_Перельмана
.pdf
20
https://t.me/medicina_free
S. V. S. Deo et al.
Fig. 3.1 Planning of incisions for breast conservation surgery for tumors in different locations of the breast
Fig. 3.2 Part of skin close or adherent to tumor is included in the incision

a Circumareolar/Langer’s lines b Resting Skin Tension lines c Radial (inferior quadrant)
Infra-mammary
3 Principles ofPlanning Incisions forBreast Oncoplasty andReconstruction
https://t.me/medicina_free
21
mmary, peri-areolar, and axillary location
(Fig.3.5) [4]. The incision may be placed directly
overlying the tumor or away from tumor with
tunneling for tumor access (indirect approach).
Axillary surgery can be done using the same
incision for upper outer quadrant and axillary tail
tumors; otherwise, a separate incision placed
behind anterior axillary fold should be used for
axillary surgery.
Preoperatively anthropometric assessment of
the patient and breast should be done. The shape
of breast, degree of ptosis, NAC size and position, and tumor location should be documented in
sitting as well as standing position. The measurements and incision on the skin should be marked
preoperatively and modications should be
made, if required, by assessing them in sitting
and standing position. Preoperative photographs
in sitting and standing position should be taken
for documentation, after due consent. This will
help in planning the reconstruction options and
also will be helpful in dealing with medicolegal
issues in future, if any.
Intraoperatively, the patient should be adequately exposed (i.e. including the contralateral
breast) and should be positioned in semi- reclining
position and have a symmetrical arm positioning.
The markings and measurements should be
rechecked intraoperatively (Fig.3.6).
Trans-axillary
Fig. 3.3 Previous surgical scar included in the denitive
surgical planning
Fig. 3.4 Planning of incisions in relation to Langer’s lines
Peri-areolar
Fig. 3.5 Anatomical locations where surgical scars can
be hidden

22
https://t.me/medicina_free
Fig. 3.6 Positioning of the patient, measurements and
markings of breast for complex breast surgeries
3.2 Incision Planning
forMastectomy
Non-skin sparing mastectomy (NSSM), skin
sparing mastectomy (SSM), skin reducing mastectomy (SRM), nipple–areola sparing mastectomy (NASM) are the four types of mastectomies
S. V. S. Deo et al.
commonly performed. Elliptical incision including NAC (except for NASM) and surrounding
skin can be utilized by placing transversely or
with an upward angle toward axilla. Transverse
incision is preferred in large breasted women,
while a sigmoid or modied wise pattern incision
is recommended for the small breasted women.
Incisions should not cross normal anatomical
boundaries of the breast such as clavicle,
inframammary crease, sternal border, and the
axillary fold.
Flaps should not be raised beyond inframammary crease, unless required. The infra- mammary
crease should be marked preoperatively.
Uninvolved skin should be preserved if delayed
or secondary reconstruction is planned.
Inframammary crease or lateral mammary
incisions may be used in cases of skin sparing or
NAC sparing mastectomy in patients with small
sized breast (Fig. 3.7) [5]. Other incisions that
may be used for NASM or SSM are peri-areolar,
trans-areolar, trans-areolar and trans-nipple, lateral mammary crease, italic “S” (Fig.3.8) [6].

3 Principles ofPlanning Incisions forBreast Oncoplasty andReconstruction
https://t.me/medicina_free
Fig. 3.7 Nipple sparing mastectomy using an inframammary incision with implant reconstruction in a case of multicentric breast cancer
Fig. 3.8 Various
incisions and approaches
for skin sparing and
nipple–areola sparing
mastectomy
23
3.3 Conclusion
Judicious planning of incisions is extremely
important to achieve good cosmetic outcomes in
breast oncoplasty. It requires familiarity with
anatomy, oncologic principles, and plastic surgical techniques. The incision planning should be
individualized and should be tailored to patient,
tumor, and treatment needs. It should aim at balancing oncologic and cosmetic outcomes.
References
1. Moufarrège R, Dionyssopoulos A, Aymeric A,
Sauvageau J. Is there a relation between mamma-
plasties incisions and the nal shape of the breast?
Ann Chir Plast Esthet. 2010;55:111–34. https://doi.
org/10.1016/j.anplas.2009.04.006.
2. Mitchell SD. A step-by-step oncoplastic breast con-
servation surgical atlas of reproducible dissection
techniques and anatomically ideal incision placement.
Breast Cancer Res Treat. 2017;165:505–16. https://
doi.org/10.1007/s10549- 017- 4344- z.

24
https://t.me/medicina_free
S. V. S. Deo et al.
3. Skaria AM. Incision lines on the female
breast. DRM. 2020;236:248–50. https://doi.
org/10.1159/000505541.
4. Seki H, Sakurai T, Maeda Y, et al. Utility of the
periareolar incision technique for breast reconstructive surgery in patients with breast cancer. Surg
Today. 2020;50:1008–15. https://doi.org/10.1007/
s00595- 020- 01975- y.
5. Daar DA, Abdou SA, Rosario L, et al. Is there a
preferred incision location for nipple-sparing mas-
tectomy? A systematic review and meta-analysis.
Plast Reconstr Surg. 2019;143:906e–19e. https://doi.
org/10.1097/PRS.0000000000005502.
6. Rawlani V, Fiuk J, Johnson SA, et al. The effect of
incision choice on outcomes of nipple-sparing mastectomy reconstruction. Can J Plast Surg. 2011;19:129–
33. https://doi.org/10.1177/229255031101900410.

Oncologic Principles ofBreast
https://t.me/medicina_free
Conservation andOncoplastic
Breast Surgery
DillipKumarMuduly andMadhabanandaKar
4
4.1 Introduction
Breast conservation surgery (BCS) refers to
resection of the tumor with a three-dimensional
grossly free margin, along with the preservation
of cosmesis. The term breast conservation therapy (BCT) is interchangeably used with BCS;
however, BCT means incorporating locoregional
radiotherapy and BCS.BCS require good surgical skills and experience and quality BCS is of
paramount importance for any successful oncoplastic breast surgical procedure.
4.2 Clinical Evaluation
andStaging
The patients with early breast cancer present with
a breast lump or may be detected on a screening
method. Triple assessment is mandatory in all
patients, including clinical examination, imaging
of breast (ultrasound and/or mammogram), and a
tissue diagnosis (core-cut biopsy). A guided corecut biopsy always gives better results. In addition
to histopathology; immunohistochemistry for
Estrogen Receptor (ER), Progesterone Receptor
(PR), and Her2neu are done in all patients, particularly those planned for neoadjuvant chemo-
D. K. Muduly (*) · M. Kar
Department of Surgical Oncology, All India Institute
of Medical Sciences, Bhubaneswar, India
therapy. Staging is performed clinically using
AJCC/TNM staging method. For clinical stage I
and II, no further metastatic staging investigations are required. For clinical stage III and IV,
we need to perform CECT Chest, abdomen, and
pelvis with Bone scan/PET scan alone as staging
investigation [1].
4.3 Local Imaging
All patients undergo a bilateral mammogram at
the time of presentation. Digital mammography
is preferred to analog mammography, particularly for women with dense breasts. The mammogram will tell if there is any lesion, whether
the lesion is solitary/multiple, the size and location of the lesion, whether unilateral or bilateral,
and the ACR density category. Information on the
mammogram helps in deciding whether BCS is
feasible or not. The ACR density category is one
of the factors in deciding the type of oncoplastic
surgery to be planned.
Ultrasound of the breast is usually performed
to conrm the results of a mammogram. The
USG of the breast would help inlocalizing and
characterizing any lesion, site, size, and the number of lesions, distance from the skin, pectoral
fascia, and nipple-areolar margin. Ultrasound is
also used to guide a biopsy and may be used
intra-operatively to localize and guide an adequate resection margin. The USG of the axilla is
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_4
25

26
https://t.me/medicina_free
D. K. Muduly and M. Kar
performed in all patients with early breast cancer
to see for any suspicious nodes before planning
for a sentinel node biopsy.
Although highly sensitive, magnetic resonance
imaging (MRI) of the breast is not performed routinely due to its low specicity. However, MRI
may be performed in addition to mammogram
and ultrasound in; (a) unknown primary with an
axillary nodal metastasis where clinical examination and conventional imaging has failed to detect
the primary lesion [2, 3], (b) There remains a high
suspicion for malignancy and US and needle
biopsy have not made a diagnosis [4], (c) The
patient has lobular cancer, and wide local excision
is being considered, (d) The examination or initial
imaging suggests there may be multi-focal disease, (e) there is discordance regarding tumor size
between the clinical examination and initial imaging or the size of the tumor cannot be reliably
assessed clinically or on imaging (this typically
includes inltrating tumors, most notably lobular
carcinomas, and when the tumor is occult on initial imaging modalities). (f) The patient has silicone implants. (g) MRI guided biopsy of a lesion
not visible on mammography or ultrasound.
4.4 Patient Selection forBreast
Conservation Surgery
All patients with early breast cancers without
absolute contra-indications can be offered breast
conservation as choice of treatment. Patients with
EBC who are unt for upfront BCS due to large
tumor size or adverse tumor versus breast ratio
can be offered NACT to downstage the disease
and facilitate BCS.
4.4.1 Absolute Contra-indications
forBCT
4.4.1.1 Contra-indication at
Presentation
If the patient is in the rst trimester of pregnancy
at presentation, she should be treated with mas-
tectomy. If she presents in the second or third trimester, she can be managed with BCS followed
by adjuvant chemotherapy or NACT followed by
surgery. Adjuvant RT can be administered
postpartum.
4.4.1.2 Contra-indication Based
onPast-history
History of prior irradiation to the chest wall.
4.4.1.3 Contra-indication onClinical
Examination
If on examination, multicentric disease is there
with two or more lumps, and they cannot be
resected without compromising cosmesis.
4.4.1.4 Contra-indication
onInvestigation
Diffuse appearing malignant microcalcication
on the mammogram.
4.4.1.5 Contra-indication Detected
On-table During Surgery
(Frozen)/Post-Surgery (Paran
Sections)
Persistent margin positive (cavity shave) after reresection of a positive margin.
4.4.2 Relative Contra-indications
toBCT
4.4.2.1 Connective Tissue Diseases
Some of the patients with connective tissue
disorders tolerate poorly to radiotherapy.
Patients with Scleroderma, Sjogren’s
Syndrome have higher complications due to
skin fragility. Systemic Lupus erythematosus
and rheumatoid arthritis patients also have an
increased risk of skin toxicity. In recent studies, there was no significant difference in the
incidence of acute or late complications.
However, there was a higher incidence of radiation complications in patients with scleroderma. No fatal complication were noted in
any of the patients [5].

4 Oncologic Principles ofBreast Conservation andOncoplastic Breast Surgery
https://t.me/medicina_free
27
4.4.2.2 Tumor Breast Ratio
This is dened as tumor size relative to breast
size and is an essential factor in selecting patients
for BCT.A large tumor in a small breast is a relative contra-indication since an adequate resection
would signicantly alter cosmetic alteration.
However, now-a-days, these patients may
undergo BCT with oncoplastic techniques/NACT
followed by BCT with/without oncoplasty.
4.4.2.3 Pendulous Breast
A pendulous breast was previously a contraindication for BCT due to difculty in reproducibility of radiation dose homogeneity. However,
these patients are no longer a contra-indication if
the dose homogeneity can be ensured.
4.4.3 Factors No Longer Contraindication toBCT
4.4.3.1 Age
Older age is no longer a contra-indication for surgery. In contrary, they have a lower risk of recurrence, and they should be offered with BCT if
there is no other contra-indication.
4.4.3.2 Tumor Location
Although the patients with a medial tumor are
challenging to reconstruct, they are not contraindications for BCT. With oncoplastic surgery,
these patients are increasingly taken up for breast
conservation.
4.4.3.3 Invasive Lobular Carcinoma
If resected up to negative margins, it’s not a
contra- indication. The presence of classic LCIS
at the resection margin does not increase the
recurrence rates and does not bear a clinical signicance and does not need a re-resection of the
margin.
4.4.3.4 Extensive Intraductal
Component (EIC)
Extensive intraductal component (EIC) means
presence of >25% volume of DCIS component
present in the resected lumpectomy specimen, in
a patient with invasive tumor. The EIC does not
apply to a tumor that is pure DCIS. The EICpositive cancers with negative resection margins
do not have an increased risk of ipsilateral recurrence following BCT [6].
4.4.3.5 Family History ofBreast Cancer
Patients with family history of breast cancer are
not contra-indication for BCT. However, they
should be informed that, they have a higher risk
of increased second primary cancers [7].
4.4.3.6 Lymph Node Positivity
Presence of positive lymph node is a marker for
poor prognosis with increased distant recurrence
and not a contra-indication for BCT.Node positive patients undergoing mastectomy or BCT
have similar outcomes.
4.4.4 Principles ofNeoadjuvant
Chemotherapy Followed
byBCT
Patients with early breast cancer unsuitable for
BCT due to large tumor size may be planned for
NACT followed by BCS. The NACT increases
the BCT rate; however, it does not impact recurrence or survival. However, all patients receiving
NACT should have undergone a core-cut biopsy
with the evaluation of ER, PR, and Her2neu status before chemotherapy. Those with negative
hormone receptors and Her2neu negative tumors
show the highest response rate. Those with hormone receptor-positive and HER2 negative are
less likely to respond to NACT or become eligible for BCT.Meticulous clinical and radiological
evaluation by the treating surgeon, precise documentation of clinical ndings, metal marker
placement in the tumor prior to NACT are essential prerequisites for NACT - BCS protocols.
Post-chemotherapy assessment includes clinical
and radiological evaluation. Wire-guided localization or any other localization method should
be used to target tumor bed with metal marker.
Volume of excision should be as per post-NACT
residual tumor burden. Specimen mammography
should be performed to conrm excision of target
lesion.

28
https://t.me/medicina_free
4.5 Surgical Principles
The incision should be planned according to the
tumor location and breast anatomy. No excessive
tunneling should be performed. During resection
care is taken to take adequate grossly normal
margin (usually 1cm) around the tumor. There
are different techniques to ensure a gross margin
of 1 cm around the tumor. The most common
technique used by the surgeons is Palpation
Guided Resection for palpable lesions. The surgeon palpates the lesion after raising the aps
when required, and the nger placed on the tumor
margin helps ensure a 1cm gross normal tissue
margin (Fig. 4.1). The USG can be used
(Ultrasound-Guided Resection), particularly in
non-palpable or indistinct lesions, to localize and
accurately ensure margins (Fig.4.2). Other techniques used for non-palpable lesions are wire-
D. K. Muduly and M. Kar
Fig. 4.2 Ultrasound-Guided Resection
Fig. 4.1 Finger Guided Resection with gross normal margin. (Art: Dr. Dipin)

4 Oncologic Principles ofBreast Conservation andOncoplastic Breast Surgery
https://t.me/medicina_free
guided resection, radio-guided occult lesion
localization (ROLL), radioactive iodine (I-125)
seed localization (RSL), and cryo-assisted localization (CAL) techniques.
4.5.1 Breast Conservation Surgery–
Margin Status
There are two types of margins described. One is
the lumpectomy margin, which can be assessed
by the following methods. After resection, the surgeon can assess the lumpectomy margin by pal-
pating the resected lumpectomy specimen for any
gross margin positivity. The surgeon takes sec-
tions on the resected primary specimen along different margins (Fig. 4.3). Ultrasound of the
lumpectomy specimen may be performed to
ensure the adequacy of gross margin (Fig.4.4).
The specimen may be sent for specimen mam-
mogram to see for adequacy of margins, particularly in non-palpable lesions (Fig.4.5). The other
is, taking margin specimen separately from the
resected cavity, also called cavity shave margins
(Fig.4.6). If available, many centers perform frozen section biopsy or imprint cytology of the
lumpectomy or cavity shave margins, which gives
an accurate intra-operative microscopic margin
status and reduces the positive margin rate and
Fig. 4.4 Intra-operative margin assessment by ultrasound. (Post-resection)
rate of re-resection. Two randomized trials have
shown cavity shave margin reduces the margin
positive rate by 50%. We at our institute routinely
perform cavity shave margins intra- operatively
and perform frozen section biopsy. Any positive
margin is immediately subjected to further reresection/mastectomy based on circumstances [8,
9].
Different newer, lesser invasive, and faster
technologies have been described that accurately
predict the microscopic margin status; however,
they are costly and unavailable at many centers,
e.g., MarginProbe, which uses spectroscopy, and
Lumicell, which uses uorescent imaging as the
principle.
Microscopic margin status is the most crucial
factor in BCT, and the currently microscopic positive margin is dened as “ink-on-tumor”. A negative microscopic margin is dened as “no ink on
tumor” [10] (Table4.1).
29
Fig. 4.3 Cut-section of the specimen to assess the gross
margin
4.5.2 Metal Marker Placement
ontheResection Cavity
After resection, meticulous hemostasis must be
obtained. Metallic titanium clips are placed on
the margins before closure to help the radiation
oncologist identify the cavity for tumor boost.
Routinely a clip is placed in each medial, lateral,
superior, inferior, and deep margins of the resection cavity (Fig.4.7).
Соседние файлы в папке Библиотека им академика М.И. Перельмана
